SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/43EEC434C5BDCA2DAF4A9504B97692AA14C1261241F07026A49A15A61D4F81060A5C85CCFF673D0800C555054CF49999>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/43EEC434C5BDCA2DAF4A9504B97692AA14C1261241F07026A49A15A61D4F81060A5C85CCFF673D0800C555054CF49999
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/43EEC434C5BDCA2DAF4A9504B97692AA14C1261241F07026A49A15A61D4F81060A5C85CCFF673D0800C555054CF49999
http://www.w3.org/2000/01/rdf-schema#comment
"Data show that in K562 cells the protein kinase C alpha (PKCalpha) and protein kinase C beta II (PKCbetaII) expressions enhanced in the presence of the drug when the growth was inhibited."
xsd:string
http://purl.uniprot.org/uniprot/#_A520B85284FB3922C8D98F18A0E8AB3FDABCB85CD73136285C8B64BBAEB2DE973896557FCE1BB3D48DB1DEC382C401C6
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/43EEC434C5BDCA2DAF4A9504B97692AA14C1261241F07026A49A15A61D4F81060A5C85CCFF673D0800C555054CF49999
http://purl.uniprot.org/uniprot/Q7Z727
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/43EEC434C5BDCA2DAF4A9504B97692AA14C1261241F07026A49A15A61D4F81060A5C85CCFF673D0800C555054CF49999
http://purl.uniprot.org/uniprot/#_Q7Z727-mappedCitation-25693686
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/43EEC434C5BDCA2DAF4A9504B97692AA14C1261241F07026A49A15A61D4F81060A5C85CCFF673D0800C555054CF49999